Invest Securities confirms its Buy rating on Assystem shares, with a price target raised from €54 to €55.

The analyst believes that the 16.4% rise in 1st-quarter sales illustrates the message conveyed by management in mid-March on the occasion of the 2022 results, namely that 'the acceleration in growth would be faster than initially envisaged'.

Given that the main bottleneck, recruitment, is also being managed fairly well (25% of recruitment planned for 2023 was completed in Q1), momentum is indeed improving in consolidated activities", the research firm points out.

Invest Securities now believes that 'the only uncertainty lies in the timing of the disposal of the Expleo and Framatome stakes', but stresses that 'more than ever, Assystem remains a strong conviction to benefit from the nuclear revival'.

Copyright (c) 2023 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.